A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood

NCT06193811 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Avenciguat (BI 685509) (intended commercial formulation (iCF))
DRUG: Avenciguat (BI 685509) (trial formulation 2 (TF2))
DRUG: esomeprazole

Sponsor

Boehringer Ingelheim